40
Participants
Start Date
August 31, 2016
Primary Completion Date
August 7, 2019
Study Completion Date
October 7, 2019
MEDI9929
MEDI9929 700mg (3 doses in total, 4-week intervals), administered intravenously
Placebo
Placebo (3 doses in total, 4-week intervals), administered intravenously
Copenhagen University Hospital Bispebjerg, Copenhagen
Lund University
OTHER
University of Newcastle, Australia
OTHER
University of Copenhagen
OTHER
Celeste Porsbjerg
OTHER